MIRA
INFORM REPORT
|
Report Date : |
28.12.2007 |
IDENTIFICATION
DETAILS
|
Name : |
MEDQUIMICA INDÚSTRIA FARMACÊUTICA LTA. |
|
|
|
|
Registered Office : |
Rua Otacilio Esteves da Silva, 40 – Granjas Betania, 36080-480 – Juiz
de Fora / MG |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Financials (as on) : |
31.12.2006 |
|
|
|
|
Date of Incorporation : |
July 21, 1975 |
|
|
|
|
Com. Reg. No.: |
31.200.519.153 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Industry of pharmaceutical products. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Company name
MEDQUIMICA INDÚSTRIA FARMACÊUTICA LTA.
Address
Rua Otacilio Esteves da Silva, 40 – Granjas Betania
36080-480 – Juiz de Fora / MG - Brasil
Phone: (55-32) 2101
4000 / 4001 / 4002 / 4003 / 4004
Web Site: www.medquimica.com.br
Legal information
Legal Status: Private
Limited Company
Incorporation date: July
21, 1975
Register number #: 31.200.519.153
Tax contributor (CNPJ): 17.875.154/0001-20
Registered Capital: R$4.235.000,00
State Registration #: 367.170.800.0047
Number of employees: 453
Branches: 03
History
Established on July 21, 1975, chartered at the State Commerce
Registration Office of Minas de Gerais (JUCEMG) under #31.200.519.153, into the
present registered name.
Partnership:
Jorge Lages de Oliveira -
99,5%
(Joined 07/1975), CPF:141.386.626-34
Evandro Rodrigues da Silva - 0,5%
(Joined 12/2003), Brazilian, CPF:005.450.486-48
Management:
Jorge Lages de Oliveira
Properties
Not informed.
Registered line of
business:
Industry of pharmaceutical products.
Main Products:
100% - Medicines
Import countries:
Not informed.
Export countries:
Not informed.
Purchases / Sales:
100% - Domestic market
Related Companies
Stock participation:
DBLU PUBLICIDADE LTDA. -
CNPJ:03.840.839/0001-26
- Jorge Lages de Oliveira -
33,3%
Financial Data
According to the Brazilian Law Private Limited Companies are not obliged
to file financial accounts for public inspection.
The following financial statement was obtained through outside sources
consulted.
Quarterly balance sheet as of 30/06/2007– US$1.00 = R$1,926
Balance sheet information for fiscal year ending:
31/12/2006 – US$1.00 = R$2,138
31/12/2005 – US$1.00 = R$2,341
Figures are in (Thousands of) Reais R$:
|
Assets |
06/2007 |
2006 |
2005 |
|
Current Assets |
21.212 |
19.643 |
15.263 |
|
Inventory |
5.845 |
5.853 |
5.123 |
|
Other Assets |
15.367 |
13.790 |
10.140 |
|
Long Term Assets |
6 |
4 |
1 |
|
Fixed Assets |
13.007 |
12.667 |
13.075 |
|
Investment |
6.897 |
6.897 |
6.897 |
|
Immovable |
5.521 |
4.972 |
5.201 |
|
Deferred |
589 |
798 |
977 |
|
Total Assets |
34.225 |
32.314 |
28.339 |
|
Liabilities |
06/2007 |
2006 |
2005 |
|
Current Liabilities |
12.613 |
10.398 |
7.869 |
|
Suppliers |
6.360 |
5.176 |
3.596 |
|
Other liabilities |
6.253 |
5.222 |
4.273 |
|
Long Term Liabilities |
8.395 |
7.555 |
6.788 |
|
Net Equity |
13.217 |
14.361 |
13.382 |
|
Capital |
4.235 |
4.235 |
4.235 |
|
Reserves |
8.474 |
8.474 |
8.474 |
|
Accumulated Profit (Loss) |
508 |
1.652 |
973 |
|
Total Liabilities |
34.225 |
32.314 |
28.339 |
|
Income Statement |
06/2007 |
2006 |
2005 |
|
Annual Net Sales |
19.084 |
35.762 |
28.690 |
|
Gross Income |
8.464 |
18.442 |
16.542 |
|
Operating Income |
(1.029) |
794 |
(688) |
|
Net Income |
(1.145) |
679 |
(716) |
|
Financial Analysis |
06/2007 |
2006 |
2005 |
|
Current Ratio |
1,68 |
1,88 |
1,93 |
|
Current Debt
Ratio |
0,95 |
0,72 |
0,57 |
|
Total Debt Ratio |
2,58 |
2,25 |
2,07 |
|
Working Capital |
$8.599 |
$9.245 |
7.394$ |
(Dollar rate US$1.00 = R$1,779 on 26/12/2007).
Banking
Banco do Brasil S/A. - branch -
0024
Remark: banking comments could not be
obtained due to legal restrictions from the Brazilian Law.
No returned checks were found either in the name of the company or
partners.
Insurance
Not informed.
Payment information
*Information obtained from outside sources and public consulted.
833 – Invoices:
Information
on purchases:
DEC/2007 Last: R$543 Average: R$2.676
Information
on invoicing:
MAR/2007 Highest: R$113.190 Average: R$14.496
Information
on accumulation:
NOV/2006 Highest: R$649.970 Average: R$78.430
100% - Prompt payments
Trade References
Main Suppliers:
Vitale Artes Gráficas S/A.
Comércio e Indústria Farmos Ltda.
Ageplast Indústria e Comércio Ltda.
Cia. Brasileira de Antibióticos – CIBRAN
Saldec Produtos Químicos e Pecuários Ltda.
Agostini Internacional Importação e Exportação Ltda.
Main clients:
Sucefarma do Brasil Ltda.
Distribuidora Capixaba de Medicamentos Ltda.
Public Records Information
No negative information was found.
Remarks
The information in this report were obtained from outside sources and
public records consulted.
Final Opinion
The company can be considered normal for business dealings at usual
trade terms and conditions.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)